|
Joseph R. Berger, M.D.
Joseph R. Berger, M.D., is the Ruth L. Works Professor and Chairman of the Department of
Neurology at the University of Kentucky College of Medicine
where he is director of the Multiple Sclerosis Clinic and
the Neuro-AIDS Program. Dr. Berger was a summa cum
laude graduate of the
Pennsylvania
State
University
–
Jefferson Medical College 5 Year Accelerated Medical Program
and is member of Alpha Omega Alpha. He completed his
residency in internal medicine at
Georgetown
University
Hospital
and
his neurology residency at the University of Miami School of
Medicine. In 1981, he joined the faculty of the
University of Miami School of Medicine serving in both the
Departments of Neurology and Internal Medicine. At
that institution, he held the Whigham-Berger
Endowed Chair for the study of the neurological
complications of HIV/AIDS. He is a fellow of the
American
Academy
of
Neurology and a member of the American Neurological
Association, currently serving as Treasurer of the latter.
His research interests include the neurological
complications of HIV/AIDS, progressive multifocal
leukoencephalopathy, multiple sclerosis, and other
inflammatory disorders of the brain. He has been the
recipient of numerous grants to support his research.
He has published more than 140 refereed papers, more than 80
chapters, and has edited three textbooks. He is an
Associate of the Journal of Neurovirology and has served or
is serving on several other editorial boards.
Research Interests:
-
Neurological Aspects of AIDS and HIV
infection
-
Infectious diseases of the nervous
system
-
Neurologic complications of systemic
illness
-
Multiple sclerosis
Current Address:
University
of Kentucky
College
of Medicine
Department of Neurology
Kentucky
Clinic,
Wing D, L-445
Lexington,
Kentucky
40536-0284
Phone:
(859) 323-6702
or
(859)
218-5039
Fax:
(859)
323-5943
E-mail:
jrbneuro@uky.edu
Current Rank
and Status:
Ruth L. Works
Professor
of
Neurology
and
Professor
of Internal
Medicine
Education:
1969
Susquehanna
Township
High
School
Harrisburg,
Pennsylvania
1972
B.S., [Summa
cum
laude]
Pennsylvania
State University University
Park, Pennsylvania
1974
M.D., [Magna
cum
laude]
Amplissimis
Honoribus Jefferson
Medical
College Philadelphia,
Pennsylvania
Overlap in
years
as undergraduate
and graduate student
results from
participation
in
the
Pennsylvania
State University - Jefferson Medical
College
Five Year
Medical
Program.
1998
Certificate in
Medical Management Gatton College
of Business
University
of Kentucky
Lexington,
Kentucky
Post
Doctoral
Training:
1974-75
Straight Internal
Medicine Internship,
Georgetown
University
Hospital,
Washington,
D.C.
1975-77
Internal
Medicine Residency,
Georgetown
University
Hospital,
Washington,
D.C.
1977-78
Neurology
Residency,
Hadassah
Hospital,
Hebrew
University,
Jerusalem, Israel
1978-81
Neurology
Residency,
Jackson
Memorial
Hospital,
University of
Miami
School
of
Medicine,
Miami,
Florida
Academic Medical
Professional
Experience:
March
-
July
1978
Full-time
emergency
room
physician Chambersburg
Hospital,
Chambersburg,
Pennsylvania
July 1981
- May
1986
Assistant
Professor
of Neurology
and Internal Medicine, University
of Miami
School
of
Medicine,
Miami,
Florida
June
1986
- June
1991
Associate Professor
of Neurology
and Internal
Medicine,
University
of Miami
School
of
Medicine,
Miami,
Florida
June
1991
- Feb 1995
Whigham-Berger
Professor
of Neurology
and
Professor
of Internal Medicine, University
of
Miami
School of
Medicine,
Miami,
Florida
Feb 1995
- Present
Professor
and
Chairman,
Department
of Neurology,
University
of Kentucky
School
of
Medicine,
Lexington,
Kentucky
July 1996-Present
Professor of Internal
Medicine
University
of Kentucky School
of
Medicine,
Lexington, Kentucky
Other Medical
Professional
Medical Experience:
Examiner,
American
Board
of Psychiatry & Neurology,
Inc.
Adult Neurology
Team
& Part II Examination
Committee,
Philadelphia,
PA, 1996-2003.
Member,
Ad Hoc Search
Committee
for the Chief Operating
Officer of the Kentucky
Clinic, 1996-Present
Chair, Search Committee for
the
Chair
of Internal Medicine,
University
of Kentucky, College
of
Medicine,
March,
1998
Medical Director,
Consultants
in Pharmaceutical
Advertising,
Key Biscayne, Florida
(CEO
Hugues
deRochefort),
1980-1994
Consultant
for Glaxo
Smith
Kline, PML
Adjudication
Committee,
Firategrast Study
2007
–
Present
Consultant for
Millenium
Pharmaceutical,
PML Adjudication Committee,
MLN02
Study,
2007
– Present
Consultant
for
Bayer/Schering/Berlex,
Multiple
Sclerosis,
2007
–Present
Board Certifications
and Licensures:
National
Board
of Medical Examiners
Licensure, July
1,
1975;
#138818
American
Board of
Internal Medicine,
1977;
#59535
American
Board
of Psychiatry
and Neurology,
1983;
#037298
Pennsylvania
Medical
License,
1979; #019628
(inactive) Florida
Medical License, 1980;
#ME
0036452
Kentucky
Medical License, March 16,
1995;
#31055
Tennessee Medical
License, July 31,
2003;
#37826
(inactive)
Published abstracts
(Select list from
more than 200):
20.
Berger JR:
Why is
PML more
prevalent
in HIV infection than
with other
predisposing
immunosuppressive
conditions?
J
Neurovirol 2003;9(Suppl
2):11-13.
19.
Avison
MJ, Nath A, Avison
RG,
Schmitt
FA, Greenberg RN,
Berger, JR:
Reduced dependence
of BBB compromise
on
microglial
activation in HIV patients
on
HAART Ann
Neurol
2003;54
(suppl
7):S48.
18.
Avison
M, Nath A, Avison
RG,
Schmitt
FA, Greenberg RN,
Berger
JR:
Viremia
in the
presence
of blood
–brain
barrier
compromise
increases
severity
of HIV-associated
neurocognitive
impairment.
Ann Neurol
2003;54
(suppl
7):S49.
17.
Berger JR,
Miller C, Mootoor
Y, Avdiushko
S, Popa
J: JCV in throat washings
of normal
and
HIV-infected
persons.
J Neurovirol
2004;10
(suppl
2):
19.
16.
Berger JR:
Progressive
multifocal
leukoencephalopathy
in the AIDS era. J
Neurovirol
2004;10
(suppl 2):
37.
15.
Berger JR,
Avison
MA,
Mootoor
Y, Beach C: Preliminary
proteomic
studies of
CSF
and
serum
in
HIV
dementia.
J Neurovirol
2004;
10 (suppl
3):62-63.
 14.
BergerJR,
Nath A,
Avison
RG,
Mootoor
Y, Greenberg RN,
Schmitt
FA, Avison MJ:
White
matter axonal
damage
is correlated
with basal
ganglia
inflammation in HIV infection.
J Neurovirol
2004;10
(suppl
3):63.
13.
Berger JR:
The varied
clinical
faces of HIV
encephalopathy.
World Journal of Biological
Psychiatry
2005;
6 (Suppl
2)
(S
061.1):
145.
12. Simpson
D,
Brown
S,
Chang
S, Jermano
J, and
C107
Study
Group:
Controlled
Study
of
High-
concentration
capsaicin
patch
for painful
HIV-associated
distal sensory polyneuropathy.
13th
Conference
on Retroviruses
and Opportunistic
Infections,
Denver,
CO,
Feburary
5-8,
2006.
11. Verma
A, Berger
JR:
Primary lateral
sclerosis with HIV-1
infection:
report of two cases and
review of
HIV-associated
motor
neuron
diseases.
11th
International
Congress
on neuromuscular
Diseases (ICNMD) 2006,
Lufti Convention
Center,
Istanbul, Turkey, July
2-7,
2006.
10.
Marzocchetti
A, Tompkins
T, Clifford
D, Ghandi R, Kesari S, Berger
JR, Simpson
DM,
deLuca
A, Koralnik
I: Interplay
of host
and
viral factors
in the clinical outcome
of
patients with
progressive
multifocal
leukoencephalopathy
(PML). 8th
International
Symposium
on Neurovirology.
J Neurovirol
2007;13(suppl
1):
102.
9. Berger
J,
Powel D,
Mootoor
Y, Given
C,
Avison
M, Reddy V,
Kryscio
R: MR abnormalities
in normal
appearing white
matter
and the response
to
interferon
beta
1b: a
pilot study.
Multiple
Sclerosis
2007; 13:S548.
8. Dobbs
M, Berger JR,
Houff
SA:
Autoimmune
disorders
associated
with carbon monoxide
poisoning.
61st
Annual
Meeting American
Academy
of Neurology,
Seattle,
Washington,
April
29, 2009.
7. Berger
JR, Houff
SA, Gurwell J, Danaher
R,
Miller C:
JC
virus expression
is unaltered
by interferon-beta
or
glatiramer
acetate(T-7). 134
Annual Meeting
of American Neurological Association,
Baltimore,
MD, October 12, 2009.
6. Vargas
DL,
Culpepper
J, Berger
JR,
McCarthy M, Tyor
W, Levin M, Bever
C, Royal
W: Concurrent
diagnosis
of
multiple
sclerosis and HIV
infection in U.S. military
veterans (T-24).
134
Annual
Meeting of American Neurological
Association,
Baltimore,
MD, October
12,
2009.
5. Houff
SA,
Berger JR: Neurological
complications
of influenza viruses:
the
rold
of dysregulation of immune
system.
(IN2-2.006)
Neurology
2010;
74 (suppl
2):A14.
4. Gjeuens
S,
Bord
E,
Desari S,
Simpson
DM,
Gandhi
RT, Clifford
DB, Berger JR,
Koralnik I: Role
of
CD4+
and CD8+ T cell responsis
against
JC virus in patients
with PML.
10th
International
Symposium
of NeuroVirology,
Milan,
Italy, October
12-16,
2010.
3.
Miller C, Danaher R,
Houff S,
Lin Y, Gurwell
J, Vega N, Hopper
J; Thomas J; Berger
JR:
.Absence
of
effect
on JC virus
expression
by disease modifying
drugs.
Consortium
of MS
Centers. Montreal,
Canada,
June
2011.
2.
Berger
J,
Boklage
S,
Patel P,
Suarez-Zambrano
G,
Pocoski
J,
Preblick:
Fatigue
as
precursor
to clinically definite
multiple
sclerosis.
Consortium
of
MS
Centers. Montreal,
Canada,
June
2011.
1. Hunter
SF,
Berger
JR,
Fanelli
MJ,
Karlsson
L, Hunter
H,
Hunter S,
Ferry JA: Cerebral toxoplasmosis
following
natalizumab
treatment
in
multiple
sclerosis. Consortium
of
MS Centers.
Montreal, Canada,
June 2011.
|
